Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

Overview of attention for article published in Molecular Cancer, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet
twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 386 Dimensions

Readers on

mendeley: 319 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

SIGMAR1 LIGAND FOR THE TREATMENT OF PANCREATIC CANCER

Application WO-2024033399-A1

World Intellectual Property Organisation (WIPO)

THE ROLE OF PMCIC IN THE TUMOR MICROENVIRONMENT

Application WO-2022013295-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.